Skilled Nursing Facility Denial Escalation
A post-acute clinical analysis for SNF admission or continued-stay denials. It focuses on the skilled need, frequency and complexity of nursing/therapy, functional status, safe lower-level alternatives, discharge barriers that are clinically material, and the applicable Medicare/Medicare Advantage or plan criteria.
A bounded clinical support service.
A post-acute clinical analysis for SNF admission or continued-stay denials. It focuses on the skilled need, frequency and complexity of nursing/therapy, functional status, safe lower-level alternatives, discharge barriers that are clinically material, and the applicable Medicare/Medicare Advantage or plan criteria.
Scope boundary. The client retains filing, portal work, deadlines, signatures, coding, legal strategy, patient care, and any required U.S.-licensed or specialty opinion unless a separate approved scope expressly says otherwise.
The decision problem this service addresses.
HHS-OIG reported in June 2026 that 19 Medicare Advantage organizations denied 12% of SNF admission requests in the reviewed month; only 18% of those denials were appealed, and 95% of appealed denials were overturned. This is a strong reason to screen SNF denials carefully, but not a promise that any individual denial is wrong or will be reversed. (HHS-OIG, 2026)
What the review must resolve.
Skilled need
Which services require licensed nursing or therapy judgment rather than custodial assistance?
Frequency and complexity
Why must those services occur at the requested frequency and in an SNF setting?
Function and safety
What mobility, cognition, ADL, fall, wound, medication, or caregiver facts affect a safe lower level?
Admission or continued stay
Which exact period is disputed, and did the clinical need change across it?
Lower-level alternative
Could home health, outpatient care, or another setting actually deliver the documented plan?
Plan pathway
Which Medicare, Medicare Advantage, Medicaid, commercial, or contract rule applies?
The clinical work product.
- Admission/continued-stay timeline.
- Evidence map for skilled need, intensity, function, risk, and feasible alternatives.
- Payer-rationale rebuttal, missing-document list, adverse facts, and appeal-writer handoff.
- Plan-specific analysis; it will not assume Medicare FFS rules automatically govern an MA or commercial contract.
What the client must supply.
Turnaround begins after the agreed record is complete and usable. New records, a different denial rationale, another review period, or a second independent issue can change scope.
- Denial or authorization notice and the exact disputed period
- Hospital discharge and SNF physician, nursing, therapy, medication, wound, and care-plan records
- Payer policy or authorized criteria source when available
- Prior authorization and appeal history
- The proposed alternative setting and documented caregiver or home support
How buyers handle the work today.
- Facility or hospital case-management/UM staff.
- Internal or outsourced physician-advisor review.
- Managed-care authorization staff and payer portal operations.
- Full-service post-acute denial vendors.
- Treating clinicians and therapy teams supplying missing documentation.
The intended role in the workflow.
The proposed service isolates clinical appeal reasoning from portal administration and high-volume authorization work. It is suited to selected denials that need deeper analysis, not routine submission.
What the service is designed to prevent.
These are not proof that a denial is wrong. They are ways a potentially supportable case becomes unfocused, overstated, or routed to the wrong capability.
- Describing dependence without identifying the skilled service
- Using family unavailability as the main medical-necessity argument
- Failing to separate admission need from later continued-stay need
- Ignoring plateau, nonparticipation, or a feasible lower-level plan
- Assuming Medicare fee-for-service language controls every plan
Market comparison and current Clinovian scope.
Comparable physician-level per-case prices are not public. Routine PA outsourcing can start at $4–$8 per authorization, but that price describes administrative processing at scale and is not a benchmark for record reconstruction or clinician analysis. (Staffingly)
Clinovian scope and pricing: Quote required under the current combined post-acute pricing. Normal public turnaround: 5–7 business days after complete usable inputs.
Final scope, fixed fee, and turnaround are confirmed before records are transferred; the Engagements & Pricing page remains the public pricing framework.
When to choose it—and when not to.
Choose it when the client can execute the appeal but needs a clinician to organize a disputed skilled-need story. Do not choose it for routine portal submission, benefit verification, or a case whose main defect is missing contemporaneous therapy/nursing documentation that cannot be cured by retrospective prose.
Send the decision, not the whole account. Fit is confirmed before records.
Provide the denial or request type, payer or plan, review stage, record size, and client-controlled deadline. No PHI is required for the initial scope review.